Abstract: Novel 3,3-diphenylpropylamines of the formula and stereoisomers and physiologically acceptable acid addition salt thereof; wherein R1, R2, R3, R4, R5, and R6 are as defined herein; methods of use thereof; and pharmaceutical compositions thereof.
Type:
Grant
Filed:
August 24, 2006
Date of Patent:
November 6, 2007
Assignee:
Pfizer Inc.
Inventors:
John Gregory Slatter, Raymond Charles Grabiak, Robert John Kaufman